FAB — Fusion Antibodies Share News
0.000.00%
- £7.42m
- £7.02m
- £1.14m
REG - Fusion Antibodies - Total Voting Rights
AnnouncementREG - Fusion Antibodies - First purchase order under MSA
AnnouncementREG - AIM - AIM Notice - 19/02/2024
AnnouncementREG - Fusion Antibodies - Grant of options and issue of shares to directors
AnnouncementREG - Fusion Antibodies - Placing to raise £1,375,000
AnnouncementREG - Fusion Antibodies - Follow-on project award and R&D update
AnnouncementREG - Fusion Antibodies - HMRC R&D tax credit
AnnouncementREG - Fusion Antibodies - Director/PDMR Shareholding
AnnouncementREG - Fusion Antibodies - Half-year Report
AnnouncementREG - Fusion Antibodies - OptiMAL collaboration agreement
AnnouncementREG - Fusion Antibodies - Half year trading update
AnnouncementREG - Fusion Antibodies - Result of AGM
AnnouncementREG - Fusion Antibodies - Block admission six monthly return
AnnouncementREG - Fusion Antibodies - Final Results
AnnouncementREG - Fusion Antibodies - Update on AI/ML-Ab service offering
AnnouncementREG - Fusion Antibodies - Appointment of interim CFO
AnnouncementREG - Fusion Antibodies - Update on AI/ML-Ab™ antibody discovery service
AnnouncementREG - Fusion Antibodies - Update on restructure and cost savings
AnnouncementREG - Fusion Antibodies - Total Voting Rights
Announcement